您的位置: 首页 > 农业专利 > 详情页

Combination therapy of tumor targeted ICOS agonists with T-cell bispecific molecules
专利权人:
F. Hoffmann-La Roche AG
发明人:
BACAC, Marina,FAUTI, Tanja,KLEIN, Christian,SAM, Johannes,UMANA, Pablo,MURR, Ramona,ZIELONKA, Joerg,HABEGGER, Lucas
申请号:
AU2018392753
公开号:
AU2018392753A1
申请日:
2018.12.20
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
The present invention relates to agonistic ICOS-binding molecules comprising at least one antigen binding domain that binds to a tumor-associated antigen and their use in combination with T-cell bispecific molecules in the treatment of cancer, the agonistic ICOS-binding molecules as such, pharmaceutical compositions comprising these molecules, and methods of using the same.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充